603077.SH
Sichuan Hebang Biotechnology Co., Ltd.
SSE · Basic Materials · Chemicals · CN
CNY 2.42
+2.11%Sep 10, 2026, 08:23 UTC
Hebang Group, controlling shareholder of Sichuan Hebang Biotechnology, released a pledge on 218 million shares and re-pledged the same number of shares to Chongqing Rural Commercial Bank Liangjiang Branch on September 9, 2026, to fund production and operations.
Source:Sep 7, 2026, 08:54 UTC
Hebang Bio's general manager Zeng Xiaoping resigned on September 4, 2026, and the company appointed Lü Wen as the new general manager on September 5, 2026.
Source:Sep 4, 2026, 08:09 UTC
Hebang Group, controlling shareholder of Hebang Bio, released a pledge on 207 million shares on 2026-09-03 and re-pledged the same number of shares to Chongqing Rural Commercial Bank Liangjiang Sub-branch, with pledge term until 2029-09-02.
Source:Aug 28, 2026, 09:09 UTC
Hebang Bio announced the completion of its plan to reduce its repurchased shares via centralized bidding, selling 176,630,700 shares (2% of total capital) for 479 million yuan.
Source:Aug 17, 2026, 12:04 UTC
Hebang Bio announced its 2026 first-half results: net profit attributable to shareholders was 380 million yuan, up 634.30% year-on-year, with revenue of 2.888 billion yuan, down 26.34%.